ArticleFrontiers in immunology2022

The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance.

Sara Ovejero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.